These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Bacci G, Ferrari S, Tienghi A, Bertoni F, Mercuri M, Longhi A, Fiorentini G, Forni C, Bacchini P, Rimondini S, De Giorgi U, Picci P. Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499 [Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. Bacci G, Picci P, Ferrari S, Sangiorgi L, Mercuri M, Bertoni F, Brach del Prever A, Tienghi A, Mancini A, Comandone A. Chir Organi Mov; 1995 Feb; 80(1):1-10. PubMed ID: 7641534 [Abstract] [Full Text] [Related]
9. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, Yamamoto N. Anticancer Res; 1998 Feb; 18(1B):657-66. PubMed ID: 9584049 [Abstract] [Full Text] [Related]
10. [Chemotherapy of osteosarcoma]. Winkler K, Bieling P, Bielack S. Z Orthop Ihre Grenzgeb; 1992 Feb; 130(4):285-9. PubMed ID: 1413973 [Abstract] [Full Text] [Related]
11. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]. Bielack S, Kempf-Bielack B, Schwenzer D, Birkfellner T, Delling G, Ewerbeck V, Exner GU, Fuchs N, Göbel U, Graf N, Heise U, Helmke K, von Hochstetter AR, Jürgens H, Maas R, Münchow N, Salzer-Kuntschik M, Treuner J, Veltmann U, Werner M, Winkelmann W, Zoubek A, Kotz R. Klin Padiatr; 1999 Feb; 211(4):260-70. PubMed ID: 10472560 [Abstract] [Full Text] [Related]
14. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Eselgrim M, Grunert H, Kühne T, Zoubek A, Kevric M, Bürger H, Jürgens H, Mayer-Steinacker R, Gosheger G, Bielack SS. Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218 [Abstract] [Full Text] [Related]
15. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases]. Chuman H, Fukuma H, Beppu Y. Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460 [Abstract] [Full Text] [Related]
16. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group. J Clin Oncol; 2008 Feb 01; 26(4):633-8. PubMed ID: 18235123 [Abstract] [Full Text] [Related]
17. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96). Jäger M, Schultheis A, Westhoff B, Krauspe R. Anticancer Res; 2005 Feb 01; 25(2A):947-54. PubMed ID: 15868932 [Abstract] [Full Text] [Related]
18. Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry. Winkler K, Bieling P, Bielack S, Delling G, Dose C, Jürgens H, Kotz R, Ritter J, Salzer-Kuntschik M. Clin Orthop Relat Res; 1991 Sep 01; (270):79-86. PubMed ID: 1715820 [Abstract] [Full Text] [Related]
19. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Bacci G, Picci P, Gherlinzoni F, Van Horn JR, Orlandi M, Normand AR, Manfrini M, Pignatti G, Campanacci M. Chemioterapia; 1986 Apr 01; 5(2):140-3. PubMed ID: 3458546 [Abstract] [Full Text] [Related]